Bora Rhim, DPM

• Clinical Instructor, VA Medical Center
• Staff Physician, University Foot and Ankle Institute
• Los Angeles, California

Individuals homozygous for 0-thalassemia mutations have severe erectile dysfunction doctor dublin buy tadacip with a mastercard, transfusion-dependent anemia relative impotence judiciary cheap tadacip online mastercard. Approximately 1: 1000 Northern Europeans are -thalassemia carriers and in the United Kingdom some 20 babies with 0 thalassemia are born annually erectile dysfunction treatment in kolkata generic tadacip 20 mg with amex, and approximately 1000 people live with the condition vegetable causes erectile dysfunction 20 mg tadacip for sale. There are an estimated 214 std that causes erectile dysfunction buy tadacip 20 mg,000 carriers in England, mainly of Cypriot, Indian, Pakistani, Bangladeshi, or Chinese origins. Mutations in the 3 end of the untranslated region of the -globin gene can lead to loss of the signal for cleavage and polyadenylation of the -globin gene transcript. In excess of 100 different mutations have been shown to cause -thalassemia, including point mutations, insertions, and base-pair deletions. These occur within both the coding and non-coding portions of the -globin genes as well as the 5 flanking promoter region, the 5 capping sequences (p. The various mutations are often unique to certain population groups and can be considered to fall into six main functional types. Mutations in the coding regions of the -globin region can also lead to cryptic splice sites. Affected individuals typically died in their teens or early adulthood from complications resulting from iron overload from repeated transfusions. However, daily use of iron-chelating drugs, such as desferrioxamine, has greatly improved their long-term survival. Individuals heterozygous for -thalassemia-thalassemia trait or thalassemia minor-usually have no symptoms or signs but do have a mild hypochromic, microcytic anemia. Homozygous individuals produce no - or -globin chains, which one might expect to cause a profound illness. It is usually a form of -thalassemia in which continued -chain synthesis compensates for the lack of and chains. HbF may account for 20% to 30% of total Hb in heterozygotes and 100% in homozygotes. Clinical Variation of the Hemoglobinopathies the marked mutational heterogeneity of -thalassemia means that affected individuals are often compound heterozygotes (p. Certain areas of the world show a high prevalence of all the hemoglobinopathies and, not unexpectedly, individuals may have two different disorders of Hb. Certain combinations can result in a previously unexplained mild form of what might otherwise be anticipated to be a severe hemoglobinopathy. For example, deletion of one or two of the -globin genes in a person homozygous for -thalassemia results in a milder illness because there is less of an imbalance in globin chain production. Some large deletions include the A-globin gene so that only the G-globin chain is synthesized. The purpose is the presymptomatic diagnosis of infants with serious hemoglobinopathies so that early treatment can be instituted and long-term complications minimized. The programs also mean that parental testing, cascade screening through the wider family, and genetic counseling, can be offered when a carrier infant is identified. The decision to perform antenatal screening is in some regions guided by the findings of an ethnicity and family history questionnaire administered to the pregnant woman. As with all screening, this program aims to reduce the burden of health care in the long term and improve quality of life. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. The first genetic disease in which a molecular basis was described, leading to a Nobel Prize. During development, it comprises a succession of different globin chains that are expressed differentially during embryonic, fetal, and adult life. The former can be subdivided by the way in which they interfere with the normal function of Hb and/or the red blood cell. The latter can be subdivided according to which globin chain is produced abnormally. Without such measures the burden of disease would be much higher; early detection facilitates early treatment and reduced morbidity from long term consequences, and in many places prenatal diagnosis for the serious disorders is accepted. Chapter 13 Immunogenetics Medicinal discovery, It moves in mighty leaps, It leapt straight past the common cold And gave it us for keeps. The superfamily has two subgroups based on the extracellular characteristics of the receptor-i. Without it we would not survive and in order to understand the inherited disorders of immunity we must look at the fundamentals of the genetic basis of immunity. Immune defense mechanisms can be divided into two main types: innate immunity, which includes a number of nonspecific systems that do not require or involve prior contact with the infectious agent, and specific acquired or adaptive immunity, which involves a tailor-made immune response that occurs after exposure to an infectious agent. Both types can involve either humoral immunity, which combats extracellular infections, or cell-mediated immunity, which fights intracellular infections. Innate Immunity the first simple defense against infection is the mechanical barrier of the skin, which functions most of the time as an impermeable barrier but in addition, the acidic pH of sweat is inhibitory to bacterial growth. Mucus membranes line the respiratory and gastrointestinal tracts, and the respiratory tract is further protected by ciliary movement. Other body fluids contain a variety of bactericidal agents, such as lysozymes in tears. If an organism succeeds in invading the body, a healthy immune system reacts immediately by recognizing the alien intruder and a chain of response is triggered. Opsonization of bacteria fixed to cell surface Ingestion G Nucleus H2O2 G Cell-Mediated Innate Immunity Phagocytosis Two major cell types go on the offensive when a foreign microorganism invades-macrophages and neutrophils. Macrophages are the mature form of circulating monocytes that migrate into tissues and occur primarily around the basement membrane of blood vessels in connective tissue, lung, liver, and the lining of the sinusoids of the spleen and the medullary sinuses of the lymph nodes. They are believed to play a key role in the orchestration of both the innate and adaptive responses, and can recognize invading microorganisms through surface receptors able to distinguishing between self and pathogen. Recognition of the foreign material leads to phagocytosis by the macrophage, followed rapidly by neutrophils recruited from the circulation during the inflammatory process. These have carbohydrate-binding receptors on their cell surface that recognize high molecular weight glycoproteins expressed on the surface of the infected cell as a result of the virus taking over the cellular replicative functions. Binding to the infected cells results in the release of a number of agents, which in turn results in damage to the membrane of the infected cell, leading to cell death. These are called the acute-phase proteins and include C-reactive protein, mannose-binding protein, and serum amyloid P component. The first two act by facilitating the attachment of one of the components of complement, C3b, to the surface of the microorganism, which becomes opsonized (made ready) for adherence to phagocytes, whereas the latter binds lysosomal enzymes to connective tissues. Complement the complement system is a complex of 20 or so plasma proteins that cooperate to attack extracellular pathogens. Although the critical role of the system is to opsonize pathogens, it also recruits inflammatory cells and kills pathogens directly through membrane attack complexes. These cytokines help mediate migration of dendritic cells from infected tissue to lymph nodes, where they may encounter and activate leukocytes involved in the adaptive immune response. The activation of the Toll pathway has several important effects in inducing innate immunity. The main functions of complement are recruitment of inflammatory cells, opsonization of pathogens, and killing of pathogens. But they were numbered in order of their discovery rather than the sequence of reactions. The other two complement pathways also converge toward C3 convertase, which cleaves C3. C3a mediates inflammation while C3b binds to the pathogen surface, coating it and acting as an opsonin. Opsonisation: C3b and C4b are opsonins that coat foreign organisms, greatly enhancing their phagocytosis-phagocytes have receptors that recognize complement proteins bound to a pathogen. Inflammation: C5a, as well as C4a and C3a, are inflammatory activators that induce vascular permeability, and recruit and activate phagocytes. Immune complex clearance: Complement has a critical role in removing immune complexes from the circulation. The immune complex binds C4b and C3b, which then binds to receptors on red blood cells and the complexes are transported to the liver and spleen, where the complexes are given up to phagocytes for destruction. There are clinical consequences relating to mutations in the genes of these pathways. Specific Acquired Immunity Many infective microorganisms have, through mutation and selective pressures, developed strategies to overcome or evade the mechanisms associated with innate immunity. There is a need, therefore, to be able to generate specific acquired or adaptive immunity. This can, as with innate immunity, be separated into both humoral and cell-mediated processes. Humoral Specific Acquired Immunity the main mediators of humoral specific acquired immunity are immunoglobulins, or antibodies. C3b attaches to the pathogen surface and binds to receptors on phagocytes, leading to opsonization. C3b can also combine with other proteins on the pathogen surface and form a membrane attack complex. Immunogenetics 167 Immunoglobulins the immunoglobulins, or antibodies, are one of the major classes of serum protein. Fc Disulphide bonds Carboxy terminal Immunoglobulin Structure Papain, a proteolytic enzyme, splits the immunoglobulin molecule into three fragments. Two of the fragments are similar, each containing an antibody site capable of combining with a specific antigen and therefore referred to as the antigen-binding fragment or Fab. The third fragment can be crystalized and was called Fc, and this component determines the secondary biological functions of antibodies, binding complement and Fc receptors on different cell types involved in the immune response. They are held together in a Y-shape by disulfide bonds and noncovalent interactions. The L chains are of two types-kappa or lambda, and these occur in all five classes of antibody, but only one type occurs in each individual antibody. In addition, there are four IgG subclasses-IgG1, IgG2, IgG3, and IgG4-and two IgA subclasses-IgA1 and IgA2-that differ in their amino acid sequence and interchain disulfide bonds. Individual antibody molecules that recognize specific antigens are known as idiotypes. Immunoglobulin Allotypes the five immunoglobulin classes occur in all normal individuals, but allelic variants, or what are known as antibody allotypes of these classes, have also been identified. These are the Gm system associated with the heavy chain of IgG, the Am system associated with the IgA heavy chain, the Km and Inv systems associated with the light chain, the Oz system for the light chain and the Em allotype for the IgE heavy chain. Immunoglobulin Isotypes, Subclasses, and Idiotypes There are five different types of heavy chain, designated respectively as, µ, and, one each for the five major antibody classes-the isotypes-IgG, IgM, IgA, IgD, and IgE, Table 13. Lymphocytes that produce antibodies express copies of the immunoglobulin (Ig) for which they code on their surface, which acts as a surface receptor for antigen. Re-exposure to the same antigen results in a swifter response and enhanced antibody levels, which is the secondary response, amounting to the antigen-specific immunological memory. Different combinations of H and L chains could, to some extent, account for this diversity. It would, however, require thousands of structural genes for each chain type to provide sufficient variability for the large number of antibodies produced in response to the equally large number of antigens to which individuals can be exposed. Our initial understanding of how this works came from persons with a malignancy of antibody-producing cells- multiple myeloma. Chromosome 2 Variable region 40 Diversity Junctional Constant region region region 5 1 Chromosome 22 30 4 7 Chromosome 14 60 27 6 11 Heavy chain Multiple Myeloma People with multiple myeloma make a single or monoclonal antibody species in large abundance, which in a proportion of patients is detected in their urine. The aminoterminal ends of this protein molecule in different patients are quite variable in sequence, whereas the carboxy-terminal ends are relatively constant. Class Switching of Antibodies There is a normal switch of antibody class produced by B cells on continued, or further, exposure to antigen-from IgM, the initial class of antibody produced in response to exposure to an antigen, to IgA or IgG. Analysis of class switching in a population of cells derived from a single B cell has shown that both classes of antibody have the same antigen-binding sites, having the same V region but differing only in their C region. This group of structurally similar molecules has been called the immunoglobulin superfamily (p. It consists of eight multigene families that, in addition to the and L-chains and different classes of H-chain, include the chains of the T-cell receptor (p. Cell-Mediated Specific Acquired Immunity Certain microorganisms, viruses, and parasites live inside host cells. As a result, a separate form of specific acquired immunity has developed to combat intracellular infections involving lymphocytes differentiated and matured in the thymus-hence T cells. Today we have monoclonal antibodies (mAb) and, for almost any substance, it is possible to create a specific antibody that binds that substance. Monoclonal antibodies are the same because they are made by one type of immune cell which are all clones of a unique parent cell. In the 1970s it was found that the B-cell cancer, multiple myeloma, produced a single type of antibody-a paraprotein. This facilitated the study of the structure of antibodies but it was not possible to produce identical antibodies specific to a given antigen. Typically, mAb are made by fusing myeloma cells with spleen cells from a mouse (or rabbit) that has been immunized with the desired antigen. They are then grown in medium which is selective for these hybrids-the spleen cell partner supplies hypoxanthine-guanine-phosphoribosyl transferase and the myeloma has immortal properties because it is a cancer cell. The antibodies secreted by different clones are assayed for their ability to bind the antigen, and the healthiest clone selected for future use. The hybrids can also be injected into the peritoneal cavity of mice to produce tumors containing antibody-rich ascitic fluid, and the mAb then has to be extracted and purified. Some T cells become helper cells and secrete some cytokines that attract fresh macrophages, neutrophils and other lymphocytes, and other cytokines to direct the recruits once they arrive on the scene.

While the exact mechanism is unknown erectile dysfunction commercials discount tadacip 20 mg buy on-line, 266 267 Chapter 42: Periocular Infections bacterial lipases may result in the formation of free fatty acids erectile dysfunction treatment muse order tadacip 20 mg line, which increase the melting point of the lipids synthesized by the meibomian glands and prevent its expression from the glands impotence at 50 20 mg tadacip purchase fast delivery, leading to instability of the tear film and ocular irritation erectile dysfunction yahoo answers 20 mg tadacip visa. However erectile dysfunction treatment with exercise buy generic tadacip 20 mg, a broad initial differential can avoid misdiagnosis: · Orbital cellulitis is distinguished from blepharitis by the presence of more systemic symptoms, tender sinuses, and sometimes limited extraocular movements. Differentiating between the different types of blepharitis is difficult; fortunately, it is typically not necessary for management purposes. Many cases There are no specific laboratory tests or radiographic findings for blepharitis. It is possible to do a microbial culture of the eyelid by swabbing the eyelashes, but this is usually not necessary. Apply warm compresses to the eyelids for several minutes to soften adherent scurf or discharge and warm meibomian gland secretions. The warm compress may consist of a clean cloth soaked in hot tap water, or a bag of rice or gel pack heated in a microwave. Vertical massage of the eyelid may help with meibomian gland secretion expression. Gently cleanse the eyelashes using diluted baby shampoo or commercially available eyelid cleansers using a pad, cotton ball, cotton swab, or clean fingertip. Once- or twice-daily compresses and massage, as well as regular eyelid cleansing (daily or several times weekly) is generally adequate for symptomatic control. A topical antibiotic ointment such as bacitracin or erythromycin can be applied topically to the eyelid margins one or more times daily, or at bedtime, for a few weeks. For those unresponsive to these ointments, metronidazole gel is an alternative treatment. The frequency and duration of treatment depends on the severity of disease and response to treatment. Tetracyclines have been shown to decrease bacterial lipase production and demonstrated efficacy in the treatment of meibomian gland dysfunction. Oral doxycycline or minocycline 100 mg can be given daily, to be tapered to 40 to 50 mg daily after clinical improvement is noted (usually 2­6 weeks). Alternatively, oral erythromycin (250­500 mg daily) or azithromycin (250­500 mg, one to three times a week, or 1 g per week for three weeks) may be used. Treatment can be intermittently discontinued and restarted based on the severeity of symptoms and medication tolerance. Omega 3-fatty acid supplementation (two 1,000 mg capsules three times a day) has been shown to improve symptoms in some patients. A brief course of topical corticosteroid such as fluorometholone twice daily may help improve symptoms. Referral to an ophthalmologist is indicated in such cases, as topical steroids can have adverse effects, such as intraocular pressure elevation. If artificial tears are used more than four times per day, non-preserved tears should be used to avoid preservative toxicity. Otherwise, both present as visible, palpable, subcutaneous nodules, often with swelling and/or tenderness. Not indicated unless there is concern for a malignant process masquerading as a chalazion. A chalazion is a focal area of inflammation within the eyelid due to an obstructed meibomian gland or gland of Zeis. A hordeolum is an infection of a meibomian gland (also called "inernal hordeolum") or gland of Zeis (also called "external hordeolum"). They are more commonly encountered in patients with meibomian gland disease and rosacea. It is prudent not to misdiagnose sebaceous cell carcinoma as a recurrent chalazion, as they may present similarly. Oral doxycycline 100 mg twice daily can also be considered for its antibacterial and anti-inflammatory effect. Consider congenital encephalocele in a neonate and lacrimal sac tumor in an adult if there is involvement above the medial canthus. Approximately 20% of neonates have excess tearing due to delayed canalization; however, spontaneous resolution occurs in over 90% of cases within the first year of life. Neonates with an imperforate valve of Hasner are at increased risk of developing nasolacrimal duct obstruction and subsequent dacryocystitis. Acquired dacryocystitis in adults is also usually secondary to nasolacrimal duct obstruction, which is typically idiopathic, but can be due to malignancy. Those at higher risk for acquired dacryocystitis include females, those with flatter noses and narrower faces, and age greater than 40. Obtain a gram stain and culture of any discharge to help guide antibiotic therapy. Afebrile adults and children can be managed as outpatients with appropriate antibiotics (see Table 42. This can be considered if medical management fails and requires referral to an ophthalmologist. Adults often require surgical correction following resolution of the infection (dacryocystorhinostomy). Dacryocystitis can progress to orbital cellulitis and has been reported to lead to orbital abscess as well as cavernous sinus thrombosis. Periorbital and Orbital Cellulitis Epidemiology and Microbiology Orbital and periorbital (or preseptal) cellulitis are commonly encountered problems in the acute care setting. Periorbital cellulitis arises from minor skin trauma, insect bites, and underlying sinusitis and dacrocystitis, and less commonly from bacteremia. Orbital cellulitis is usually due to underlying sinusitis and the common pathogens are S. Streptococcus anguinosus, an oral commensal, was a common isolate in a recent case series. Fungal pathogens (Mucormycosis and others) are the cause of highly aggressive orbital cellulitis in immunocompromised adults. Differential Diagnosis · Dacryocystocele is an enlargement of a non-inflamed lacrimal sac due to nasolacrimal duct obstruction secondary to an imperforate valve of Hasner. Canaliculitis typically presents as unilateral tearing with chronic mucopurulent conjunctivitis. Often, concretions consisting of sulfur granules can be expressed on · 269 270 Chapter 42: Periocular Infections Table 42. Topical antibiotic drops can be used in addition to systemic therapy, but their use alone is not adequate. Both periorbital and orbital cellulitis are more prevalent in children than adults, with incidence of periorbital cellulitis peaking in younger children (3 to 36 months of age). Laboratory and Radiographic Findings There are no definitive laboratory tests for periorbital and orbital cellulitis. Blood cultures are generally recommended in the pediatric population, where up to one-third of patients may have positive cultures, as well as in febrile adults. Cultures of eye secretions may be confusing because of contaminants; in general, such cultures should not be used to narrow antibiotic therapy, but rather to identify possible antibiotic-resistant organisms. The most specific cultures are from sinus contents or abscess material if surgically drained. Because most cases of periorbital and orbital cellulitis occur in children, the decision to proceed with imaging is generally based on clinical exam. In children where vision cannot be accurately assessed, the threshold for imaging should be lowered. Furthermore, even if orbital involvement seems certain on exam, imaging may help direct surgical drainage. Axial and coronal views are necessary: the former to evaluate for brain abscess in the parenchyma, and the latter for any subperiorbital processes. Orbital ultrasonography is also used in some institutions, but is extremely operator dependent. Treatment and Prophylaxis Although children with periorbital cellulitis were previously hospitalized for observation, the trend is toward outpatient management with close follow-up for patients who do not appear toxic. Patients with periorbital cellulitis who are less than 1 year of age or toxic-appearing should be treated for orbital cellulitis. There is limited data regarding the optimal duration of therapy, and the most conservative recommendation is for outpatient antibiotics for 2 to 3 weeks after clinical improvement 271 272 Chapter 42: Periocular Infections Table 42. Same as for non-immunocompromised persons and children, but awareness that other infections (particularly fungal causes) could be present as well. Initial treatment would be the same, but additional fungal cultures should be sent if fungal causes are suspected and then treated with amphotericin B. Complications include subperiostial abscess, orbital abscess, extraorbital extension, 272 273 Chapter 42: Periocular Infections including cavernous sinus thrombosis and brain abscess, and blindness. Untreated orbital cellulitis can be fatal in up to 17% of patients and lead to blindness in the affected eye of approximately 20% of patients. With proper treatment of orbital cellulitis, the rate of visual loss is still 3 to 10% and mortality 1 to 2%. Permanent vision loss can occur from orbital cellulitis by two mechanisms: (1) increased intraorbital pressure causing damage to the optic nerve; or (2) direct extension of infection into the optic nerve. Patients with altered level of consciousness and ocular infections should be evaluated for meningitis and intracranial abscess formation, which can be extensions of orbital cellulitis. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Perform a complete examination of the globe, especially the conjunctiva and cornea, for ocular herpes simplex or herpes zoster ophthalmicus. Congenital dacryocystitis in neonates should be treated aggressively because the orbital septum is not fully formed and extension of the infection can lead to brain abscesses and sepsis. This condition can also be associated with amniotocele (when amniotic fluid is retained in the lacrimal sac because of an obstructed nasolacrimal duct) and requires probing of the duct. Severe cases of dacryocystitis can manifest by pupillary dysfunction due to increased intraorbital pressure and its effects on pupillomotor fibers in the orbit. Orbital cellulitis should be strongly considered in the setting of pupillary dysfunction, diplopia, or loss of peripheral vision. Squamous, basal, and sebaceous cell cancers can sometimes be misdiagnosed as chronic dacryocystitis. Mucormycosis, Aspergillus) orbital cellulitis in immunosuppressed adults, which can be lethal. The general term "uveitis" most commonly refers to anterior uveitis, which includes iritis and inflammation of other structures of the anterior chamber. If inflammation is located in the vitreous humor, it is sometimes termed intermediate uveitis. While the definitive diagnosis and management of infectious uveitis is beyond the scope of most acute care providers, it is important to be able to distinguish these deep-seated and sight-threatening infections from more routine and superficial problems such as conjunctivitis and corneal abrasion. Uveitis and Retinitis Epidemiology and Microbiology the annual incidence of uveitis is about 40 new cases per 100,000, with anterior uveitis accounting for approximately 75% of cases. Similarly, posterior uveitis of infectious origin can be caused by many different agents. Ocular toxoplasmosis may occur in infants via vertical transmission from mothers who are infected during pregnancy. In ocular toxoplasmosis, parasites accumulate primarily on the retina and can spread to the choroid and sclera. Clinical Features Most patients with anterior uveitis will present with a red eye. In general, patients with eye complaints associated with photophobia, decreased visual acuity, or pain that is not relieved by anesthetic drops should undergo a slit lamp exam. Since the majority of cases of uveitis are associated with systemic disesase, a complete history and physical exam looking for clues to systemic illness is essential (see Table 43. Coccidioides Cryptococcus Histoplasma Sporotrichosis (Sporothrix schenckii) Parasitic (protozoan/helminthic): Toxoplasmosis gondii Acanthamoeba Cysticercosis Onchocerciasis Pneumocystis carinii Toxocariasis Anterior uveitis: · pain · redness · photophobia · ciliary flush (ring of red at corneal limbus) · white blood cells and "flare" (haze caused by extravasated plasma proteins) in anterior chamber Posterior uveitis: · Blurred vision, usually painless and without photophobia · typically no conjunctival redness · macular edema · perivascular retinal exudates · choroidal and retinal inflammatory lesions · · white blood cells and flare in the anterior chamber deep pain (where conjunctivitis, and episcleritis may have some irritation, uveitis is typically described as a "deeper pain") Laboratory Findings Uveitis is a clinical diagnosis that should be made in conjunction with an ophthalmologist who can perform a detailed eye exam and follow the patient over time. When an infectious etiology is suspected, other clinical manifestations of the disease may help make the diagnosis. Testing for tuberculosis exposure and serologic testing for syphilis and connective tissue disease is often appropriate, and generally will be directed by the consultant. Infectious uveitis should be treated with the general systemic treatment of the underlying infection. In many cases, there is good ocular penetration from the systemic medication and no local ocular antimicrobial treatment is required. In immunocompromised patients, uveitis may be due to chronic infections such as toxoplasmosis, syphilis, tuberculosis, coccidioidomycosis, and histoplasmosis. Ophthalmologists should be closely involved in the management of these patients to monitor for resolution of ocular findings. Patients may have only a simple complaint of decreased vision (usually bilateral) and be without pain, redness, or appreciable intraocular inflammation. Signs and symptoms Key features that may help to distinguish anterior uveitis from conjunctivitis, keratitis, and episcleritis are: · "ciliary flush," or perilimbal (the intersection of the sclera and cornea) injection · photophobia Endophthalmitis Acute bacterial endophthalmitis is a vision-threatening condition and must be managed as an emergency. But endophthalmitis can also be caused by ocular trauma and bacteremia, and acute care providers should be familiar with the clinical features of these infections. The clinical outcome depends both on the virulence of the infecting organism and on the speed with which appropriate therapy is initiated. In the United States, the most common form of endophthalmitis is acute endophthalmitis after cataract surgery. Cataract surgery involves entering the anterior chamber with instruments and can, on occasion, result in disruption of the vitreous humor during surgical manuevers.

Inducible clindamycin resistance is detected in the laboratory by the simple D-zone disk diffusion test erectile dysfunction when young trusted tadacip 20 mg, which now is performed routinely in most laboratories erectile dysfunction foods generic tadacip 20 mg with mastercard. In the acute care setting erectile dysfunction drugs covered by medicare tadacip 20 mg order online, the main impact of this issue is that it increases the importance of obtaining blood cultures erectile dysfunction hormonal causes tadacip 20 mg order free shipping, and other culture specimens whenever possible erectile dysfunction causes alcohol order tadacip with mastercard, before initiating antibiotics. Refer to the corresponding chapters for complete empiric drug selection and dosing. Complete treatment regimens for these infection types can be found in the corresponding chapters elsewhere in this textbook. If available, results of recent, relevant culture results should always be used to select initial antibiotics. Several points should be borne in mind when choosing an oral agent for skin abscesses and purulent cellulitis. Therefore, use of clindamycin or addition of a beta-lactam, "just in case" it is a streptococcal infection, is unnecessary. While a single double-strength tablet twice a day is sufficient in most uncomplicated infections, the largest adult trial of trimethoprim­sulfamethoxazole for simple skin abscesses used two double-strength tablets, and this dosing should be considered in more serious infections (extensive purulent cellulitis) and in obese patients. With regard to serious and invasive infections requiring parenteral therapy, vancomycin is the drug of choice in the emergency setting in most cases. Most experts recommend a 20 to 25 mg/kg initial loading dose; the previously common practice of simply giving 1 g is therefore inadequate for most adults. Vancomycin levels are monitored by measuring trough levels at steady state, usually after three to four doses. For severe infections, a trough of 15 to 20 mg/L is generally recommended, while 10 to 15 mg/L may be appropriate for less serious infections. In the emergency setting, administering an appropriate initial dose expedites the achievement of adequate trough levels. Hand hygiene and frequent decolonization of potential fomites are likely the most important measures. These range from a self-limited infection with no discernable complication, as in the case of a simple furuncle that ruptures on its own, to invasive infection such as pneumonia or endocarditis complicated by rapid development of septic shock and death. Disease-specific complications are discussed in detail in the corresponding chapters in this textbook. In such cases, a very low threshold should be maintained for obtaining blood cultures and advanced imaging. Wash hands frequently with soap and water or alcohol-based hand gel and always wash after touching infected wounds or soiled bandages. While there is wound drainage, do not participate in activities involving skin-to-skin contact or in contact sports. Clean contaminated environmental surfaces and equipment with a detergent or disinfectant that specifies S. Severe community-onset pneumonia in healthy adults caused by methicillinresistant Staphylococcus aureus carrying the Panton­Valentin leukocidin genes. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Clindamycin versus trimethoprim­sulfamethoxazole for uncomplicated skin infections. Care should be taken not to under-dose vancomycin; the initial loading dose is generally 20mg/kg. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. Introduction and Microbiology the enterococci are gram-positive cocci, formerly considered group D streptococci, but now recognized to be a unique genus, which commonly colonize the human gastrointestinal and genitourinary tracts. Owing to intrinsic resistance to many advanced penicillins, cephalosporins, and clindamycin, the traditional mainstay treatments for enterococcal infections have been ampicillin (or penicillin) and vancomycin. Vancomycin impairs gram-positive cell wall synthesis by binding to the terminus of the cell wall precursor. Vancomycin resistance in Enterococcus is encoded by a cluster of resistance genes, the most common and well studied of which is termed vanA, which result in production of an altered cell wall precursor that does not bind vancomycin. Acute care providers must be familiar with the risk factors for Epidemiology Enterococcus colonizes the gastrointestinal tract of both humans and livestock. Once gastrointestinal colonization is established, the organism is shed in stool and found on skin, urinary catheters, and hospital surfaces. Compounding the problem of infection control, Enteroccoccus survives readily for days on fomites such as hospital surfaces. In most cases, the empiric antibiotic regimen should simply be based on the hospital antibiogram or national guidelines. In such cases, treatment decisions should be made in conjunction with an infectious disease specialist, if possible. Institutions that restrict the use of specific antimicrobial agents based upon cost or other features should consider placing exceptions in their policy for urgent first-dose administration in the emergency department (see Table 76. While there are no distinct clinical features associated with Enterococcus, in general Enterococcus is less virulent than other uropathogens like E. The biggest challenge is differentiating acute infection from colonization and asymptomatic bacteriuria, which should not be treated except in pregnant women. The threshold for treatment should be lower in patients with compromised immune function. Patients with fever or sepsis, however, should begin empiric therapy for endocarditis or catheter-associated bacteremia. In the case of ampicillin resistance, alternate oral drugs include nitrofurantoin, fosfomycin, doxycycline, or linezolid. If the isolate is ampicillin resistant, the main choices are daptomycin or linezolid. For ampicillin-susceptible isolates, ampicillin plus aminoglycoside is often the preferred treatment. The aminoglycoside are added to achieve bactericidal activity in the setting of bloodstream or other life-threatening infection. The theoretical advantage of daptomycin is its bactericidal activity, while the drawback is its inactivation by lung surfactant, making it less effective if pneumonia is the primary source of bacteremia. Linezolid is bacteriostatic and associated with a host of adverse effects such as peripheral neuropathy and bone marrow toxicity with prolonged administration. Laboratory Findings Enterococcus may be isolated from any of several clinical specimens, including blood, urine, cerebrospinal fluid, and wound material. Three blood cultures should be obtained to help differentiate skin contamination from bacteremia. In patients with chronic indwelling urinary catheters, urine cultures should be taken from a freshly inserted catheter. Dosing does not reflect recommended changes for end-organ dysfunction or morbid obesity. It is associated with numerous adverse effects, including painful arthralgias and myalgias. Antibiotic selection should be managed by an infectious disease specialist in such cases. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the American Heart Association. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Disease Society of America. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Clinical practice guidelines for the diagnosis and management of intravascular catheterrelated infection: 2009 updated by the Infectious Disease Society of America. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the united states, 2000­2006. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the national healthcare safety network at the center for disease control and prevention, 2009­ 2010. Complications and Admission Criteria Standard admission criteria apply to enterococcal infections. Edwards 77 Outline Introduction and Microbiology 552 Epidemiology 552 Clinical Features 553 Laboratory Features 553 Treatment and Prophylaxis 553 Infection Control 554 Complications and Admission Criteria 554 Pearls and Pitfalls 554 References 554 Table 77. Compounding the problem of antimicrobial resistance in gram-negative pathogens is the recent emergence of carbapenemase-producing Enterobacteriaceae, particularly Klebsiella species. Infections with these pathogens leaves clinicians with virtually no available antibiotic treatment. Introduction and Microbiology Antibiotics belonging to the beta-lactam class all contain a betalactam ring in their structure and work by inhibiting bacterial cell wall biosynthesis. This broad class of antibiotics includes the penicillins, cephalosporins, carbapenems, and monobactams. Beta-lactamases are enzymes produced by bacteria that cleave the beta-lactam ring, rendering otherwise effective antibiotics largely powerless. In 1940, even before the widespread clinical use of penicillin, the first beta-lactamase-producing strain of E. Since then, the development of new betalactam antibiotics has focused largely on strategies to overcome this important mechanism of bacterial resistance. The development of third-generation cephalosporins, such as ceftriaxone, in the 1980s was considered a major step forward in the battle against beta-lactamase-producing organisms. Over 1,000 unique beta-lactamase enzymes have been subsequently identified that vary in their exact means of genetic transmission and molecular mechanisms of resistance and the types of antibiotics they are capable of inactivating. Environmental, animal, and food contamination outside the hospital has also been documented. The clinical features of these infection types can be found in the relevant chapters in this textbook. Resistance to at least one extended-spectrum cephalosporin (either ceftazidime, cefepime, cefotaxime, or ceftriaxone) is found in over 12% of Escherichia coli isolates and over 25% of Klebsiella spp. For patients with indwelling urinary catheters, it is important to obtain the urine specimen for culture from a newly inserted urinary catheter whenever possible. In most cases, the empiric antibiotic therapy should be selected based on the suspected source of infection, hospital antibiogram or evidence-based guideline recommendations, and clinical judgment. Antibiotics in the new cephalosporin-beta-lactamase inhibitor class show promise, but are not yet widely recommended. Tigecycline has been used effectively in the hospital setting, but is not considered first line. Institutions that restrict the use of carbapenems in the emergency setting because of cost should consider placing exceptions in their policy for urgent first-dose administration in certain situations. Cefoxitin and cefotetan, sometimes used for empiric treatment of intra-abdominal infections, may be effective. Agents from these classes may be used if culture results return showing susceptibility. An oral fluoroquinolone is a reasonable treatment of such infections if the isolate is known to be susceptible. For isolates that are multidrug resistant, treatment options include oral fosfomycin and intramuscular ertapenem ­ which requires that patients return daily to the emergency department or clinic (see Table 77. Carbapenems are administered parenterally and require hospitalization or home infusion therapy. Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: a prospective study. A multinational survey of risk factors for infection with extended-spectrum betalactamase-producing enterobacteriaceae in nonhospitalized patients. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gramnegative bacteria. Community-associated extendedspectrum -lactamase-producing Escherichia coli infection in the United States. Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae. Clinical characteristics and outcomes of patients with extended-spectrum beta-lactamaseproducing bacteremias in the emergency department. Beyond susceptible and resistant, part I: treatment of infections due to gram-negative organisms with inducible betalactamases. Comparison of three biochemical tests for rapid detection of extended-spectrum -lactamase-producing Enterobacteriaceae. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009­2010. Fluoroquinoloneresistant and extended-spectrum -lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections ­ needs, advances, and future prospects. Although the distinction between these is not always absolute (some drugs can be bacteriostatic against certain organisms and bactericidal against others, or bactericidal at some concentrations and bacteriostatic at others), there are a few cases in which bactericidal activity is preferred. Foremost among these conditions are meningitis and endocarditis, where clinical studies have documented a lower cure rate with bacteriostatic drugs. Other conditions that generally call for bactericidal therapy include osteomyelitis, febrile neutropenia, and septic shock.

Order tadacip 20 mg online. How I Reversed My Husband’s Erectile Dysfunction.

Syndromes

• Touchy or easily annoyed
• Radiation to the abdomen
• Stretching and strengthening exercises are important. However, starting these exercises too soon after an injury can make your pain worse. A physical therapist can help you know when to begin stretching and strengthening exercises and how to do them.
• Surgery
• Medications or medical treatments, such as cancer chemotherapy or radiation treatment
• Within 24 hours of quitting: Your risk of a sudden heart attack goes down.
• T (thymus derived) lymphocyte count
• Hematoma (blood accumulating under the skin)
• Vomiting

Thus over the counter erectile dysfunction pills uk purchase tadacip 20 mg amex, identification and treatment of persons with latent infection is a major priority erectile dysfunction drugs malaysia purchase tadacip. Pathogenesis and Risk Factors the development of tuberculosis can be thought of as a twophase process: the acquisition of M erectile dysfunction korean red ginseng buy tadacip 20 mg amex. Infection occurs when a susceptible individual is exposed to a person with active tuberculosis erectile dysfunction after radical prostatectomy treatment options purchase 20 mg tadacip free shipping. The most common route of transmission is inhalation of aerosolized particles of approximately 1 to 5 m generated when a person with active disease coughs erectile dysfunction 5k purchase cheapest tadacip and tadacip. In heavily exposed individuals, there is a 30% chance of infection; it is estimated that as few as five viable bacilli delivered to a terminal alveolus can cause infection. In the majority of cases, infected patients with an intact immune system will experience few or no symptoms after the initial exposure. Both innate and adaptive host defense mechanisms prevent active disease in most persons, but are unable to eliminate the tubercle bacilli, leading to a "latent" infected state. Although little is known about this pathologic state, histopathological animal model studies have demonstrated that granulomas are formed through the sensitized immune response at approximately 4 weeks: lymphocytes surround the initial macrophage and neutrophil responders to the mycobacterial infection, and sequester the bacilli. Some bacilli may escape this initial immune response and disseminate to organs outside of the lungs producing other latent foci of infection. Mycobacteria have also been shown to adapt to the immune response through decreased metabolism and develop resistance to hostile environmental elements, which may help explain how latent bacteria can remain viable for decades. Approximately 3 to 5% of immunocompetent individuals will bypass a latent infection and develop active tuberculosis within 1 year of becoming infected, with an additional 3 to 5% progressing to active tuberculosis within their lifetime after a prolonged latent infection. Thus, 90% of infected, healthy persons will never develop clinical manifestations of tuberculosis. The likelihood of developing active tuberculosis is related to both host and environmental factors. Other conditions associated with impaired cell-mediated immunity also increase the risk of tuberculosis. Conditions such as diabetes mellitus and uremia are also associated with increased risk. Cigarette smoking, for instance, has a well-documented association with active tuberculosis and worse treatment outcomes. Pulmonary silicosis also increases the risk of tuberculosis, presumably because of the effects of silica on alveolar macrophage function. In addition to associated medical conditions and environmental exposures, age has a marked effect on the development of tuberculosis. The elderly and young children are at increased risk for developing tuberculosis and disseminated disease. The majority of child cases occur between the ages of 1 and 4, with one in four infections manifesting as extrapulmonary. Children under 4 years of age are more likely to experience hematogenous dissemination of mycobacteria and are at an increased risk of tubercular meningitis. Clinical Features Current guidelines recommend targeted screening of persons at high risk for the development of active tuberculosis. The guidelines emphasize that a decision to screen implies a decision to treat if the screening test is positive. Screening should be performed in those with increased risk of recent infection. General Manifestations of Tuberculosis the clinical presentation of tuberculosis varies tremendously depending on the affected site or sites of disease, the effectiveness of host defense mechanisms in containing the infection, 309 310 Chapter 47: Tuberculosis Table 47. The systemic symptoms associated with active tuberculosis include fever, night sweats, malaise, anorexia, and weight loss. Fever is the most common systemic complaint, occurring in approximately 35 to 80% of cases. Additionally, children under 5 years of age are more likely to have subtle or atypical clinical presentations. For unclear reasons, neuropsychological changes such as depression and hypomania have also been reported in association with active tuberculosis. As these factors may obscure typical presenting symptoms, a high index of suspicion is often necessary to make the diagnosis of tuberculosis. Life-threatening disease involving the meninges, brain parenchyma, and pericardium can occur. Depending on the site of involvement, patients with extrapulmonary tuberculosis may present with painless lymphadenopathy, abdominal pain, dysuria, monoarticular joint swelling, back pain, headache, cranial nerve impairments, altered mental status, focal neurological symptoms, or seizures, in addition to or instead of cough. Latent Tuberculosis Infection Latent tuberculosis infection is a clinical condition characterized by evidence of prior M. Consequently, persons with latent tuberculosis infection are asymptomatic and have normal chest radiographs. The only evidence of tuberculosis infection is an immune response to tuberculosis antigens demonstrated through a tuberculin skin test or through interferon gamma release assays. Pulmonary Tuberculosis Pulmonary involvement is the most common manifestation of tuberculosis, occurring in approximately 80% of cases. As the disease progresses and tissue necrosis occurs, the cough typically becomes productive. Pleuritic chest pain may result from inflammation of lung parenchyma adjacent to a pleural surface, pleural effusion, or an empyema. Physical findings are non-specific and generally not helpful in distinguishing tuberculosis from other pulmonary infections. Crackles can be heard in areas of pulmonary involvement, and bronchial breath sounds may indicate areas of consolidation. Differential Diagnosis the differential diagnosis of tuberculosis is broad and depends on the suspected site of infection. There are no key features that can reliably distinguish tuberculosis from other pulmonary infections. Extrapulmonary disease occurs in approximately 310 311 Chapter 47: Tuberculosis · · · · · · patients typically have demographic characteristics that place them at risk for tuberculosis Other conditions to consider are as follows: other bacterial pneumonia may cause cavitary pulmonary lesions. Staphylococcus aureus, gram-negative rods, and anaerobes) other mycobacterial pneumonias. Reading of the test is conventionally done after 48 to 72 hours, but may be delayed up to 1 week. Reaction size is determined by measuring the diameter of induration and is recorded in millimeters. Recommended cutoffs for a positive test vary with the population being tested (see Table 47. Intermediate-risk persons (health-care workers, residents of correctional facilities or nursing homes, homeless persons, and children <4 years old) have a cut-off of 10 mm. Low-risk persons (routine job screening) have the highest cut-off of 15 mm and in general should not be tested. Laboratory and Radiographic Findings Although laboratory studies are often normal, there are a few non-specific abnormalities that may be associated with active tuberculosis. The most common hematologic abnormalities in tuberculosis are an elevation in the peripheral blood leukocyte count and anemia, which occur in 10% of patients without bone marrow involvement. Other reported hematologic abnormalities include leukopenia and elevations in the peripheral blood monocyte and eosinophil counts. Hyponatremia is a fairly common metabolic effect of tuberculosis, occurring in up to 11% of patients in one report. In acute primary tuberculosis, chest radiography commonly shows middle or lower lung zone infiltrates with ipsilateral hilar lymphadenopathy. Cavitation may occur if the primary process persists (progressive primary tuberculosis). In reactivation tuberculosis, abnormalities are typically present in the upper lobe of one or both lungs. The most common sites of involvement are the apical and posterior segments of the right lung and the apical-posterior segment of the left lung. The development of a fibrotic scar with loss of lung parenchymal volume and calcification is seen with healing of tuberculous lesions. A miliary pattern of involvement may be seen when a tuberculous focus erodes into lymph or blood vessels allowing for dissemination of tuberculous bacilli. Although recognition of the classic findings in primary and reactivation tuberculosis remains important, the time from acquisition of infection to development of clinical disease may not reliably predict the radiographic appearance of tuberculosis. Although widely used, the tuberculin skin test has problems with both specificity and sensitivity. Unlike the tuberculin skin test, these assays are performed on blood specimens and therefore do not require patient follow-up for interpretion of results. Test results can be available within 24 hours, and cut-offs for positive test results are the same regardless of the population being tested. Microbiologic Diagnosis: Pulmonary Tuberculosis the definitive diagnosis of pulmonary tuberculosis is most often made through the isolation of M. Residents and employees of high-risk congregate settings, including health-care facilities, prisons and jails, long-term care facilities, and homeless shelters 4. Persons with silicosis, diabetes mellitus, chronic renal failure, hematologic disorders. Children <4 years of age and all children exposed to adults in high risk categories Reaction 15 mm of Induration 1. The most effective is sputum induction by inhalation of nebulized 3 to 7% hypertonic saline. Sputum induction is well tolerated, inexpensive, and has a similar sensitivity to bronchoalveolar lavage. Pulmonary secretions containing tuberculous bacilli are frequently swallowed and can be recovered from the gastric contents. In young children who cannot voluntarily expectorate sputum, early morning sampling of gastric contents via a nasogastric tube is often performed, though sputum induction has been shown to be safe and to have a yield comparable to or better than gastric lavage even in children as young as 1 month old. Fiberoptic bronchoscopy is often the next diagnostic modality if sputum inductions are negative or cannot be performed. The diagnosis of pulmonary tuberculosis can also be made clinically in the absence of positive cultures, though this approach does not allow for the determination of drug susceptibility and is not standard of care. In a high-risk patient, resolution or improvement of radiographic changes following antituberculosis chemotherapy is sufficient to make the diagnosis of pulmonary tuberculosis and to necessitate a complete course of therapy. In general, a clinical response should be seen within 2 months of initiating treatment. Treatment the treatment of active tuberculosis and latent infections is reviewed in Tables 47. General Principles the goals of antituberculosis therapy include achieving cure without relapse of disease, stopping transmission of M. Tuberculosis treatment differs from that of many other infectious diseases in that the responsibility for ensuring treatment completion lies with the treating clinician. For each individual patient, special consideration should be given to the specific clinical and social context in which tuberculosis treatment is being administered. Directly observed therapy (providing medications and watching the patient swallow them) is recommended for all patients and has been shown to increase compliance and completion of therapy. Tuberculosis is generally treated through public health agencies because of the significant infrastructure and cost of administering directly observed therapy. Active tuberculosis should never be treated with a single drug, Microbiologic Diagnosis: Extrapulmonary Tuberculosis the diagnosis of extrapulmonary tuberculosis is challenging. Sites of infection may be difficult to access and often contain relatively few bacilli. The cornerstone of diagnosis remains isolation of tuberculous bacilli from suspected sites of infection. Multiple samples from all affected sites should be sent for culture to maximize the diagnostic yield for both smear and culture analysis. If possible, fluid from the suspected site of infection should be aspirated ­ it takes 5,000 to 10,000 mycobacteria 312 313 Chapter 47: Tuberculosis Table 47. Jasmer, Update on the treatment of tuberculosis and latent tuberculosis infection. Cultures should always be obtained after 2 months of treatment because positive cultures at this stage predict a high risk of relapse and mandate prolongation of therapy. Drug susceptibility testing should be performed on the initial culture and again if cultures remain positive after 3 months of treatment. Tuberculosis treatment with combination chemotherapy can be complicated by both mild and serious adverse reactions (see Table 47. Mild adverse reactions can generally be managed with conservative therapy aimed at controlling symptoms, whereas with more severe reactions the offending drug or drugs must be discontinued. Although it is important to recognize the potential for adverse effects, first-line drugs should not be discontinued without adequate justification. Treatment is generally initiated with an empiric four-drug regimen consisting of isoniazid, rifampin, ethambutol, and pyrazinamide. Recommended dosages and dosing schedules for first-line antituberculosis medications are shown in Table 47. A special warning is needed about the use of fluoroquinolones in empirically treating infections in the acute care setting. To minimize the potential development of fluoroquinolone-resistant tuberculosis, this class of medication should be avoided in patients in whom tuberculosis is part of the differential diagnosis and in whom a trial of empiric antibiotics is planned. The continuation phase should be extended 3 months (total treatment duration 9 months) if cavitation was present on the initial chest radiograph and the repeat tuberculosis culture is positive. The 9-month regimen is preferred over 6 months, as it is more efficacious if adhered to . Asymptomatic elevations in liver enzymes are relatively common, but the rate of symptomatic hepatitis is low (1 to 3 per 1,000 persons treated). In a recent randomized controlled trial, combination therapy with isoniazid and rifapentine, administered as 12 directly observed weekly doses over 3 months, was found to be non-inferior to 9 months of daily self-administered isoniazid in select populations and was associated with higher treatment completion rates (82. Subjects in the combination therapy group were more likely to experience adverse events necessitating drug discontinuation (4.

References

• Kacker A, Heier L, Jones J: Large intraosseous arteriovenous malformation of the maxilla - a case report with review of literature, Int J Pediatr Otorhinolaryngol 52:89-92, 2000.
• Chakrabarti A, Pearce JM. Scapuloperoneal syndrome with cardiomyopathy: Report of a family with autosomal dominant inheritance and unusual features. J Neurol Neurosurg Psychiatry. 1981;44(12):1146-1152.
• Heubner O. Zur Topographie der Ernahrungsgebiete der einzelnen Hirnarterien. Zentralbl Med Wissenschaften 1872;10:817.
• Strauss RG. Transfusion therapy in neonates. Am J Dis Child. 1991;145:904-91.
• Sandercock P, Lindley R, Wardlaw J, et al. Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials 2008;9:37.
• Muschter, R., Gilling, P. Lasers for median lobe hyperplasia. Curr Urol Rep 2001;2:306-310.